219 related articles for article (PubMed ID: 23794315)
1. Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug.
Zawilska JB; Wojcieszak J
Hum Psychopharmacol; 2013 Sep; 28(5):403-12. PubMed ID: 23794315
[TBL] [Abstract][Full Text] [Related]
2. From local to global-fifty years of research on Salvia divinorum.
Casselman I; Nock CJ; Wohlmuth H; Weatherby RP; Heinrich M
J Ethnopharmacol; 2014 Feb; 151(2):768-83. PubMed ID: 24315983
[TBL] [Abstract][Full Text] [Related]
3. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.
Johnson MW; MacLean KA; Reissig CJ; Prisinzano TE; Griffiths RR
Drug Alcohol Depend; 2011 May; 115(1-2):150-5. PubMed ID: 21131142
[TBL] [Abstract][Full Text] [Related]
4. Salvia divinorum use and phenomenology: results from an online survey.
Sumnall HR; Measham F; Brandt SD; Cole JC
J Psychopharmacol; 2011 Nov; 25(11):1496-507. PubMed ID: 20937616
[TBL] [Abstract][Full Text] [Related]
5. Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage).
Bücheler R; Gleiter CH; Schwoerer P; Gaertner I
Pharmacopsychiatry; 2005 Jan; 38(1):1-5. PubMed ID: 15706458
[TBL] [Abstract][Full Text] [Related]
6. Salvinorin A content in legal high products of Salvia divinorum sold in Mexico.
Hernández-Bello R; García-Rodríguez RV; García-Sosa K; Peña-Rodríguez LM; Vázquez-Hernández M; Ramos-Morales FR; Corcoran O; Sánchez-Medina A
Forensic Sci Int; 2015 Apr; 249():197-201. PubMed ID: 25710779
[TBL] [Abstract][Full Text] [Related]
7. Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland.
Giroud C; Felber F; Augsburger M; Horisberger B; Rivier L; Mangin P
Forensic Sci Int; 2000 Aug; 112(2-3):143-50. PubMed ID: 10940599
[TBL] [Abstract][Full Text] [Related]
8. [Salvinorin A and related diterpenes--biological activity and potential therapeutic uses].
Piekielna J; Fichna J; Janecka A
Postepy Biochem; 2012; 58(4):485-91. PubMed ID: 23662442
[TBL] [Abstract][Full Text] [Related]
9. Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
Cunningham CW; Rothman RB; Prisinzano TE
Pharmacol Rev; 2011 Jun; 63(2):316-47. PubMed ID: 21444610
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activity of salvinorin A, the major component of Salvia divinorum.
Listos J; Merska A; Fidecka S
Pharmacol Rep; 2011; 63(6):1305-9. PubMed ID: 22358078
[TBL] [Abstract][Full Text] [Related]
11. Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.
Valdés LJ
J Psychoactive Drugs; 1994; 26(3):277-83. PubMed ID: 7844657
[TBL] [Abstract][Full Text] [Related]
12. Pattern of use and subjective effects of Salvia divinorum among recreational users.
González D; Riba J; Bouso JC; Gómez-Jarabo G; Barbanoj MJ
Drug Alcohol Depend; 2006 Nov; 85(2):157-62. PubMed ID: 16720081
[TBL] [Abstract][Full Text] [Related]
13. Salvia divinorum and salvinorin A: an update on pharmacology and analytical methodology.
Grundmann O; Phipps SM; Zadezensky I; Butterweck V
Planta Med; 2007 Aug; 73(10):1039-46. PubMed ID: 17628834
[TBL] [Abstract][Full Text] [Related]
14. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
Cruz A; Domingos S; Gallardo E; Martinho A
Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
[TBL] [Abstract][Full Text] [Related]
15. Analytical investigation of legal high products containing Salvia divinorum traded in smartshops and internet.
Xavier Moreira F; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
Forensic Sci Int; 2014 Sep; 242():255-260. PubMed ID: 25093918
[TBL] [Abstract][Full Text] [Related]
16. Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum.
Shirota O; Nagamatsu K; Sekita S
J Nat Prod; 2006 Dec; 69(12):1782-6. PubMed ID: 17190459
[TBL] [Abstract][Full Text] [Related]
17. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum.
Capasso R; Borrelli F; Capasso F; Siebert DJ; Stewart DJ; Zjawiony JK; Izzo AA
Neurogastroenterol Motil; 2006 Jan; 18(1):69-75. PubMed ID: 16371085
[TBL] [Abstract][Full Text] [Related]
18. Salvinorin A: from natural product to human therapeutics.
Vortherms TA; Roth BL
Mol Interv; 2006 Oct; 6(5):257-65. PubMed ID: 17035666
[TBL] [Abstract][Full Text] [Related]
19. Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans.
Maqueda AE; Valle M; Addy PH; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; González M; Claramunt J; Barker S; Johnson MW; Griffiths RR; Riba J
Int J Neuropsychopharmacol; 2015 Jun; 18(12):. PubMed ID: 26047623
[TBL] [Abstract][Full Text] [Related]
20. Salvia divinorum: exposures reported to a statewide poison control system over 10 years.
Vohra R; Seefeld A; Cantrell FL; Clark RF
J Emerg Med; 2011 Jun; 40(6):643-50. PubMed ID: 19765944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
